Abstract
Inhibition of digestive enzymes is one of the most widely studied mechanisms for the treatment of obesity and its associated diseases as diabetes mellitus, coronary heart diseases or sleep-breathing disorders [1, 2]. The use of plant based resources as a potential platform for discovery and development of new drugs has become a lucrative research field in this context.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
